Provided by Tiger Trade Technology Pte. Ltd.

PMGC Holdings

5.19
-0.1200-2.26%
Post-market: 5.00-0.1900-3.66%19:42 EDT
Volume:28.79K
Turnover:150.57K
Market Cap:4.20M
PE:0.00
High:5.38
Open:5.31
Low:5.06
Close:5.31
52wk High:2,671.20
52wk Low:5.06
Shares:809.58K
Float Shares:764.19K
Volume Ratio:0.34
T/O Rate:3.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1,801.7300
EPS(LYR):-3,806.9050
ROE:-105.22%
ROA:-32.97%
PB:0.25
PE(LYR):0.00

Loading ...

Why PMGC Holdings Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket

Benzinga
·
Mar 30

Stocks to Watch: PMGC, Cue Biopharma

Dow Jones
·
Mar 28

PMGC Shares Soar After Subsidiary Amends License Agreement

Dow Jones
·
Mar 28

NorthStrive Biosciences signs third amendment to MOA Life Plus license agreement; EL-32 and EL-22 clinical development milestones shift

Reuters
·
Mar 28

Northstrive Biosciences Signs Licensing Agreement Amendment With Moa Life Plus [Kosdaq: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination With Glp-1 Treatments

THOMSON REUTERS
·
Mar 28

PMGC Holdings subsidiary Northstrive Biosciences amends MOA Life Plus license agreement; payment to MOA due within 30 days of March 24, 2026 effective date

Reuters
·
Mar 27

PMGC Holdings Subsidiary Gains ITAR Defense Compliance Status

TIPRANKS
·
Mar 24

PMGC subsidiary completes ITAR registration

TIPRANKS
·
Mar 24

Svm Machining, Inc. Secures Itar Registration, Enabling Entry Into U.S. Defense Manufacturing Contracts

THOMSON REUTERS
·
Mar 24

SVM Machining secures ITAR registration

Reuters
·
Mar 24

PMGC Holdings Announces 1-for-6 Reverse Stock Split

TIPRANKS
·
Mar 11

PMGC announces initiation of preclinical study for EL-32

TIPRANKS
·
Mar 10

Pmgc Holdings Inc - Study Initiation Underway With Dosing and Observation Over Next Several Months

THOMSON REUTERS
·
Mar 10

Northstrive Biosciences Announces Launch of El-32 Preclinical Study Evaluating Muscle Preservation in Glp-1 Weight Loss Therapy

THOMSON REUTERS
·
Mar 10

NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy

GlobeNewswire
·
Mar 10

PMGC Holdings Inc trading halted, news pending

TIPRANKS
·
Mar 10

PMGC announces 1-for-6 reverse stock split

TIPRANKS
·
Mar 05

BRIEF-Pmgc Holdings Announces Anticipated Reverse Stock Split

Reuters
·
Mar 05

Pmgc Holdings Inc - to Effect 1-for-6 Reverse Stock Split Effective March 10, 2026

THOMSON REUTERS
·
Mar 05

PMGC Holdings Enters Fourth Secured Pre-Paid Equity Deal

TIPRANKS
·
Mar 03